| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 36,347 | 32,861 | 30,987 | 30,581 | | Cost of Revenue | 6,951 | 6,077 | 6,155 | 6,648 | | | Gross Profit | 29,396 | 26,784 | 24,832 | 23,933 | | | Operating Expenses | | Research Development | 7,271 | 7,078 | 6,164 | 5,388 | | Selling General and Administrative | 16,956 | 15,896 | 14,469 | 14,610 | | Non Recurring |
-
| 1,102 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,169 | 2,708 | 4,199 | 3,935 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (177) | 56 | 66 | 199 | | Earnings Before Interest And Taxes | 5,197 | 2,764 | 4,265 | 4,134 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 5,197 | 2,764 | 4,265 | 4,134 | | Income Tax Expense | 1,617 | 1,071 | 1,507 | 450 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,580 | 1,693 | 2,758 | 3,684 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,580 | 1,693 | 2,758 | 3,684 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,580 | $1,693 | $2,758 | $3,684 |
|
0.51% Nasdaq 
Income Statement
